Yunnan Institute of Microbiology, Yunnan University, Kunming, Yunnan 650091, People's Republic of China.
J Nat Prod. 2011 Sep 23;74(9):1990-5. doi: 10.1021/np200603g. Epub 2011 Aug 26.
Our current natural product program utilizes new actinomycetes originating from unexplored and underexplored ecological niches, employing cytotoxicity against a selected panel of cancer cell lines as the preliminary screen to identify hit strains for natural product dereplication, followed by mechanism-based assays of the purified natural products to discover potential anticancer drug leads. Three new linear polyketides, actinopolysporins A (1), B (2), and C (3), along with the known antineoplastic antibiotic tubercidin (4), were isolated from the halophilic actinomycete Actinopolyspora erythraea YIM 90600, and the structures of the new compounds were elucidated on the basis of spectroscopic data interpretation. All four compounds were assayed for their ability to stabilize the tumor suppressor programmed cell death protein 4 (Pdcd4), which is known to antagonize critical events in oncogenic pathways. Only 4 significantly inhibited proteasomal degradation of a model Pdcd4-luciferase fusion protein, with an IC50 of 0.88±0.09 μM, unveiling a novel biological activity for this well-studied natural product.
我们目前的天然产物项目利用源自未开发和开发不足的生态位的新型放线菌,以对选定的癌细胞系进行细胞毒性作为初步筛选,以识别天然产物去重复的命中菌株,然后对纯化的天然产物进行基于机制的测定,以发现潜在的抗癌药物先导物。三种新的线性聚酮类化合物,放线多孢菌素 A(1)、B(2)和 C(3),以及已知的抗肿瘤抗生素结核菌素(4),从嗜盐放线菌 Actinopolyspora erythraea YIM 90600 中分离得到,根据光谱数据分析阐明了新化合物的结构。所有四种化合物都被检测了其稳定肿瘤抑制蛋白程序性细胞死亡蛋白 4(Pdcd4)的能力,已知该蛋白拮抗致癌途径中的关键事件。只有 4 显著抑制了 Pdcd4-荧光素酶融合蛋白的蛋白酶体降解,IC50 为 0.88±0.09 μM,揭示了这种经过充分研究的天然产物的新的生物学活性。